Literature DB >> 17372684

Modified paclitaxel-loaded nanoparticles for inhibition of hyperplasia in a rabbit arterial balloon injury model.

Lin Mei1, Hongfan Sun, Xu Jin, Dunwan Zhu, Rui Sun, Minfang Zhang, Cunxian Song.   

Abstract

PURPOSE: This study tested the possibility of localized intravascular infusion of positive charged paclitaxel-loaded nanoparticles (NPs) to better prevent neointimal formation in a rabbit carotid artery injury model.
MATERIALS AND METHODS: NPs were prepared by oil-water emulsion/solvent evaporation technique using biodegradable poly (lactide-co-glycolide) (PLGA). A cationic surfactant, didodecyldimethylammonium bromide (DMAB), was absorbed on the NP surface by electrostatic attraction between positive and negative charges. NPs were characterized in such aspects as size, surface morphology, surface charges as well as in vitro drug release profile. Balloon injured rabbit carotid arteries were treated with single infusion of paclitaxel-loaded NP suspension and observed for 28 days. The inhibitory effects of NPs on neointima formation were evaluated as end-point.
RESULTS: NPs showed spherical shape with a diameter ranging from 200 to 500 nm. Negatively charged PLGA NPs shifted to positive after the DMAB modification. The in vitro drug release profile showed a biphasic release pattern. Morphometric analyses on the retrieved artery samples revealed that the inhibitory effect of intima proliferation was dose-dependent. At a concentration of 30 mg ml(-1), NP infusion completely inhibited intima proliferation in a rabbit vascular injury model.
CONCLUSIONS: Paclitaxel-loaded NPs with DMAB modification were proven an effective means of inhibiting proliferative response to vascular injury in a rabbit model.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17372684     DOI: 10.1007/s11095-006-9214-z

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.580


  36 in total

1.  Intramural methotrexate therapy for the prevention of neointimal thickening after balloon angioplasty.

Authors:  D W Muller; E J Topol; G D Abrams; K P Gallagher; S G Ellis
Journal:  J Am Coll Cardiol       Date:  1992-08       Impact factor: 24.094

2.  Use of a perforated balloon catheter to deliver concentrated heparin into the wall of the normal canine artery.

Authors:  H Wolinsky; S N Thung
Journal:  J Am Coll Cardiol       Date:  1990-02       Impact factor: 24.094

Review 3.  Stent development and local drug delivery.

Authors:  E Regar; G Sianos; P W Serruys
Journal:  Br Med Bull       Date:  2001       Impact factor: 4.291

4.  Arterial remodeling after coronary angioplasty: a serial intravascular ultrasound study.

Authors:  G S Mintz; J J Popma; A D Pichard; K M Kent; L F Satler; C Wong; M K Hong; J A Kovach; M B Leon
Journal:  Circulation       Date:  1996-07-01       Impact factor: 29.690

5.  Arterial uptake of biodegradable nanoparticles for intravascular local drug delivery: results with an acute dog model.

Authors:  C Song; V Labhasetwar; X Cui; T Underwood; R J Levy
Journal:  J Control Release       Date:  1998-07-31       Impact factor: 9.776

6.  Local delivery of biodegradable microparticles containing colchicine or a colchicine analogue: effects on restenosis and implications for catheter-based drug delivery.

Authors:  I Gradus-Pizlo; R L Wilensky; K L March; N Fineberg; M Michaels; G E Sandusky; D R Hathaway
Journal:  J Am Coll Cardiol       Date:  1995-11-15       Impact factor: 24.094

7.  Locally delivered nanoencapsulated tyrphostin (AGL-2043) reduces neointima formation in balloon-injured rat carotid and stented porcine coronary arteries.

Authors:  Shmuel Banai; Michael Chorny; S David Gertz; Ilia Fishbein; Jianchuan Gao; Louise Perez; Galila Lazarovichi; Aviv Gazit; Alexander Levitzki; Gershon Golomb
Journal:  Biomaterials       Date:  2005-02       Impact factor: 12.479

8.  Localized arterial wall drug delivery from a polymer-coated removable metallic stent. Kinetics, distribution, and bioactivity of forskolin.

Authors:  T L Lambert; V Dev; E Rechavia; J S Forrester; F Litvack; N L Eigler
Journal:  Circulation       Date:  1994-08       Impact factor: 29.690

9.  Arterial uptake of biodegradable nanoparticles: effect of surface modifications.

Authors:  V Labhasetwar; C Song; W Humphrey; R Shebuski; R J Levy
Journal:  J Pharm Sci       Date:  1998-10       Impact factor: 3.534

10.  Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery.

Authors:  Jeffrey W Moses; Martin B Leon; Jeffrey J Popma; Peter J Fitzgerald; David R Holmes; Charles O'Shaughnessy; Ronald P Caputo; Dean J Kereiakes; David O Williams; Paul S Teirstein; Judith L Jaeger; Richard E Kuntz
Journal:  N Engl J Med       Date:  2003-10-02       Impact factor: 91.245

View more
  13 in total

Review 1.  Nanocarriers for tracking and treating diseases.

Authors:  Sean Marrache; Rakesh Kumar Pathak; Kasey L Darley; Joshua H Choi; Dhillon Zaver; Nagesh Kolishetti; Shanta Dhar
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530

2.  Mesoscale nanoparticles selectively target the renal proximal tubule epithelium.

Authors:  Ryan M Williams; Janki Shah; Brandon D Ng; Denise R Minton; Lorraine J Gudas; Christopher Y Park; Daniel A Heller
Journal:  Nano Lett       Date:  2015-03-26       Impact factor: 11.189

3.  Statistical design for formulation optimization of hydrocortisone butyrate-loaded PLGA nanoparticles.

Authors:  Xiaoyan Yang; Sulabh Patel; Ye Sheng; Dhananjay Pal; Ashim K Mitra
Journal:  AAPS PharmSciTech       Date:  2014-02-07       Impact factor: 3.246

4.  Controlled block copolymer micelle formation for encapsulation of hydrophobic ingredients.

Authors:  Jérôme G J L Lebouille; Leo F W Vleugels; Aylvin A Dias; Frans A M Leermakers; Martien A Cohen Stuart; Remco Tuinier
Journal:  Eur Phys J E Soft Matter       Date:  2013-09-26       Impact factor: 1.890

5.  Subcritical CO2 sintering of microspheres of different polymeric materials to fabricate scaffolds for tissue engineering.

Authors:  Manjari Bhamidipati; BanuPriya Sridharan; Aaron M Scurto; Michael S Detamore
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2013-08-15       Impact factor: 7.328

6.  A new hydrotropic block copolymer micelle system for aqueous solubilization of paclitaxel.

Authors:  Kang Moo Huh; Hyun Su Min; Sang Cheon Lee; Hong Jae Lee; Sungwon Kim; Kinam Park
Journal:  J Control Release       Date:  2007-11-22       Impact factor: 9.776

7.  Nanoparticles of Poly(Lactide-Co-Glycolide)-d-a-Tocopheryl Polyethylene Glycol 1000 Succinate Random Copolymer for Cancer Treatment.

Authors:  Yuandong Ma; Yi Zheng; Kexin Liu; Ge Tian; Yan Tian; Lei Xu; Fei Yan; Laiqiang Huang; Lin Mei
Journal:  Nanoscale Res Lett       Date:  2010-05-06       Impact factor: 4.703

8.  A Promising Emodin-Loaded Poly (Lactic-Co-Glycolic Acid)-d-α-Tocopheryl Polyethylene Glycol 1000 Succinate Nanoparticles for Liver Cancer Therapy.

Authors:  Hongyan Liu; Meng Gao; Hong Xu; Xin Guan; Li Lv; Sa Deng; Chenghong Zhang; Yan Tian
Journal:  Pharm Res       Date:  2015-09-03       Impact factor: 4.200

Review 9.  Current advances in research and clinical applications of PLGA-based nanotechnology.

Authors:  Jian-Ming Lü; Xinwen Wang; Christian Marin-Muller; Hao Wang; Peter H Lin; Qizhi Yao; Changyi Chen
Journal:  Expert Rev Mol Diagn       Date:  2009-05       Impact factor: 5.225

10.  Paclitaxel Nano-Delivery Systems: A Comprehensive Review.

Authors:  Ping Ma; Russell J Mumper
Journal:  J Nanomed Nanotechnol       Date:  2013-02-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.